Meeting highlights from the Committee for Medicinal Products for Human Use,17-20 September 2007
Press releaseHuman
Meeting highlights from the Committee for Medicinal Products for Human Use, 17-20 September 2007
Reference Number: EMEA/323703/2007 - corr
English (EN) (71.21 KB - PDF)
First published:
Last updated:
Related information
Questions and answers on recommendation for the refusal of the marketing authorisation for Mylotarg : International non-proprietary name (INN): gemtuzumab ozogamicin
Reference Number: EMEA/318553/2007
English (EN) (41.61 KB - PDF)
First published:
Last updated:
Questions and answers on the marketing authorisation for vectibix : International non-proprietary name (INN): panitumumab
Reference Number: EMEA/405113/2007
English (EN) (42.25 KB - PDF)
First published:
Last updated:
Questions and answers on recommendation for the refusal of a change to the marketing authorisation for NutropinAq
Adopted
Reference Number: EMEA/423515/2007
English (EN) (43.35 KB - PDF)
First published:
Last updated:
Questions and answers on the CHMP recommendation to allow Viracept back onto the market
Reference Number: EMEA/413449/2007
English (EN) (45.27 KB - PDF)
First published:
Last updated:
Questions and answers on the Committee for Medicinal Products for Human Use recommendation on nimesulide-containing medicines
Reference Number: EMEA/430988/2007
English (EN) (36.45 KB - PDF)
First published:
Last updated:
Contact point
Media enquiries only to:
Martin Harvey Allchurch or Monika Benstetter
Tel. (44-20) 74 18 84 27
E-mail: press@ema.europa.eu